Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

131 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Why we should improve current practice of diagnosing and treating pulmonary large cell neuroendocrine carcinomas in patients with advanced disease.
Derks J, van Suylen RJ, Thunnissen E, den Bakker M, Groen H, Smit E, Damhuis R, van den Broek E, Speel EJ, Dingemans AC. Derks J, et al. Among authors: damhuis r. Eur Respir J. 2017 Oct 26;50(4):1701658. doi: 10.1183/13993003.01658-2017. Print 2017 Oct. Eur Respir J. 2017. PMID: 29074548 Free article. No abstract available.
Molecular Subtypes of Pulmonary Large-cell Neuroendocrine Carcinoma Predict Chemotherapy Treatment Outcome.
Derks JL, Leblay N, Thunnissen E, van Suylen RJ, den Bakker M, Groen HJM, Smit EF, Damhuis R, van den Broek EC, Charbrier A, Foll M, McKay JD, Fernandez-Cuesta L, Speel EM, Dingemans AC; PALGA-Group. Derks JL, et al. Among authors: damhuis r. Clin Cancer Res. 2018 Jan 1;24(1):33-42. doi: 10.1158/1078-0432.CCR-17-1921. Epub 2017 Oct 24. Clin Cancer Res. 2018. PMID: 29066508
A Population-Based Study of Outcomes in Surgically Resected T3N0 Non-Small Cell Lung Cancer in The Netherlands, Defined Using TNM-7 and TNM-8; Justification of Changes and an Argument to Incorporate Histology in the Staging Algorithm.
Blaauwgeers H, Damhuis R, Lissenberg-Witte BI, de Langen AJ, Senan S, Thunnissen E. Blaauwgeers H, et al. Among authors: damhuis r. J Thorac Oncol. 2019 Mar;14(3):459-467. doi: 10.1016/j.jtho.2018.10.164. Epub 2018 Nov 5. J Thorac Oncol. 2019. PMID: 30408568 Free article.
Disease relapse in relation to lymph node sampling in lung carcinoid patients.
Moonen L, Derks JL, Hillen LM, van Suylen RJ, den Bakker MA, Thüsen JHV, Damhuis RA, Buikhuisen WA, van den Broek EC, Maessen J, Maat APWM, van Schil P, Speel EJM, Dingemans AC. Moonen L, et al. Among authors: damhuis ra. Endocr Relat Cancer. 2024 Jul 8;31(9):e230202. doi: 10.1530/ERC-23-0202. Print 2024 Sep 1. Endocr Relat Cancer. 2024. PMID: 38855984
Identification of Defined Molecular Subgroups on the Basis of Immunohistochemical Analyses and Potential Therapeutic Vulnerabilities of Pulmonary Carcinoids.
Leunissen DJG, Moonen L, von der Thüsen JH, den Bakker MA, Hillen LM, van Weert TJJ, Zur Hausen A, van den Bosch TPP, Lap LMV, Damhuis RA, Reynaert NL, van den Broek EC; PALGA group; Fernandez-Cuesta L, Foll M, Alcala N, Sexton-Oates A, Dingemans AC, Speel EM, Derks JL. Leunissen DJG, et al. Among authors: damhuis ra. J Thorac Oncol. 2024 Nov 22:S1556-0864(24)02481-X. doi: 10.1016/j.jtho.2024.11.018. Online ahead of print. J Thorac Oncol. 2024. PMID: 39581377 Free article.
OTP, CD44, and Ki-67: A Prognostic Marker Panel for Relapse-Free Survival in Patients with Surgically Resected Pulmonary Carcinoid.
Moonen L, Derks JL, den Bakker MA, Hillen LM, van Suylen RJ, von der Thüsen JH, Lap LMV, Marijnissen BJCA, Damhuis RA, Smits KM, van den Broek EC, Buikhuisen WA; PALGA group; Dingemans AC, Speel EJM. Moonen L, et al. Among authors: damhuis ra. Mod Pathol. 2024 Dec 2;38(3):100677. doi: 10.1016/j.modpat.2024.100677. Online ahead of print. Mod Pathol. 2024. PMID: 39631518 Free article.
131 results